HPV Testing and Pap Test Market to Reach $7.4 Billion by 2035

HPV testing and Pap test market is projected to grow from $2.8 billion in 2025 to $7.4 billion by 2035, registering a CAGR of 10.2% during the forecast period. The market expansion is strongly driven by the increasing global burden of cervical cancer and the growing adoption of preventive screening programs across developed and emerging economies. A major macro driver accelerating market growth is the rising incidence of cervical cancer and HPV-related diseases. According to the World Health Organization (WHO), cervical cancer remains the fourth most common cancer among women globally, with approximately 660,000 new cases and 350,000 deaths reported in 2022. Furthermore, WHO highlights that persistent high-risk HPV infection is responsible for nearly all cervical cancer cases, making early screening essential for prevention. Global health initiatives are intensifying screening efforts, with the WHO targeting 70% of women to be screened using high-performance HPV tests by 2030. This large-scale push is significantly increasing demand for HPV testing and Pap testing technologies worldwide.

Browse the full report description of “HPV Testing and Pap Test Market Size, Share & Trends Analysis Report, By Product Type (Instruments, Assay Kits & Reagents, Consumables), By Technology (PCR-based Testing, Hybrid Capture Technology, Next-Generation Sequencing, Other Molecular Methods), By End User (Hospitals, Diagnostic Laboratories, Clinics & Gynecology Centers, Home-care / Self-sampling), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/hpv-testing-and-pap-test-market

Among product types, Assay Kits & Reagents represent the fastest-growing segment, driven by their recurring demand and increasing adoption of molecular diagnostics such as PCR-based HPV testing. These kits offer high sensitivity and enable early detection, making them critical in transitioning from traditional cytology-based screening to HPV DNA testing. From an end-user perspective, diagnostic laboratories dominate the market due to centralized testing infrastructure, while home-care/self-sampling is emerging as a high-growth segment supported by increasing awareness and convenience-driven healthcare models.

Key leader transforming the HPV testing and Pap test market

• In June 2024, Roche received World Health Organization prequalification for its cobas HPV test, including self-collection capabilities. This development expands access to cervical cancer screening in low- and middle-income countries and supports the shift toward HPV-based primary screening, driving growth in the HPV testing and Pap test market.

• In February 2026, Hologic, Inc. received S. Food and Drug Administration approval for its Aptima HPV Assay for clinician-collected primary HPV screening. This approval strengthens clinical flexibility by supporting HPV primary testing, co-testing (Pap + HPV), and Pap testing, while advancing the adoption of mRNA-based diagnostics and AI-enabled cervical screening solutions in the HPV testing and Pap test market.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Technology
  • By End-User Industry
• Competitive Landscape – Roche Diagnostics, Hologic Inc, QIAGEN N.V, BD (Becton Dickinson), Abbott Laboratories, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global HPV Testing and Pap Test Market Report Segment

By Product Type

• Instruments
• Assay Kits & Reagents
• Consumables

By Technology

• PCR-based Testing
• Hybrid Capture Technology
• Next-Generation Sequencing
• Other Molecular Methods

By End User

• Hospitals
• Diagnostic Laboratories
• Clinics & Gynecology Centers
• Home-care / Self-sampling

Global HPV Testing and Pap Test Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/hpv-testing-and-pap-test-market